Category: Children

Creatine for enhancing brain performance

Creatine for enhancing brain performance

Creatine is Lerformance, well-tolerated, and cheap [ 1 ]. Am J Physiol Snhancing Metab. Additionally, some memory tasks required an initial learning phase that likely employs auxiliary aspects of cognition, such as attention. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. Amino Acids. Physiology and Behavior, 90 121— Branch JD. Creatine for enhancing brain performance

Creatine for enhancing brain performance -

Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prüllage M, et al. Mol Cell Biol. Souza MA, Magni DV, Guerra GP, Oliveira MS, Furian AF, Pereira L, et al. Mao X, Kelty TJ, Kerr NR, Childs TE, Roberts MD, Booth FW. Creatine supplementation upregulates mTORC1 signaling and markers of synaptic plasticity in the dentate gyrus while ameliorating LPS-induced cognitive impairment in female rats.

AliMohammadi M, Eshraghian M, Zarindast MR, Aliaghaei A, Pishva H. Effects of creatine supplementation on learning, memory retrieval, and apoptosis in an experimental animal model of Alzheimer disease.

Med J Islam Repub Iran. PubMed PubMed Central Google Scholar. Ramesh V, Nair D, Zhang SXL, Hakim F, Kaushal N, Kayali F, et al. Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway.

J Neuroinflamm. Brain bioenergetics during resting wakefulness are related to neurobehavioral deficits in severe obstructive sleep apnea: a 31P magnetic resonance spectroscopy study.

Dworak M, Kim T, Mccarley RW, Basheer R. Creatine supplementation reduces sleep need and homeostatic sleep pressure in rats. J Sleep Res. Roschel H, Gualano B, Ostojic SM, Rawson ES. Creatine supplementation and brain health. Dolan E, Gualano B, Rawson ES. Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury.

Eur J Sport Sci. McMorris T, Mielcarz G, Harris RC, Swain JP, Howard A. Creatine supplementation and cognitive performance in elderly individuals.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. Rawson ES, Lieberman HR, Walsh TM, Zuber SM, Harhart JM, Matthews TC. Creatine supplementation does not improve cognitive function in young adults. Physiol Behav.

Merege-Filho CAA, Otaduy MCG, De Sá-Pinto AL, De Oliveira MO, De Souza GL, Hayashi APT, et al. Does brain creatine content rely on exogenous creatine in healthy youth?

A proof-of-principle study. Appl Physiol Nutr Metab. Turner CE, Byblow WD, Gant N. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

J Neurosci. van Cutsem J, Roelands B, Pluym B, Tassignon B, Verschueren J, Pauw DEK, et al. Can creatine combat the mental fatigue-associated decrease in visuomotor skills? Med Sci Sports Exerc. Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation.

Neurosci Res. Cook CJ, Crewther BT, Kilduff LP, Drawer S, Gaviglio CM. Skill execution and sleep deprivation: effects of acute caffeine or creatine supplementation: a randomized placebo-controlled trial.

J Int Soc Sports Nutr. McMorris T, Harris RC, Swain J, Corbett J, Collard K, Dyson RJ, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol.

McMorris T, Harris RC, Howard AN, Langridge G, Hall B, Corbett J, et al. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior.

Ainsley Dean PJ, Arikan G, Opitz B, Sterr A. Potential for use of creatine supplementation following mild traumatic brain injury. Vedung F, Fahlström M, Wall A, Antoni G, Lubberink M, Johansson J, et al.

Chronic cerebral blood flow alterations in traumatic brain injury and sports-related concussions. Brain Inj. Sullivan P, Geiger J, Mattson M, Scheff S.

Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. Scheff SW, Dhillon HS. Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury.

Neurochem Res. Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin.

Masse I, Moquin L, Bouchard C, Gratton A, De Beaumont L. Efficacy of prophylactic versus therapeutic administration of the NMDA receptor antagonist MK on the acute neurochemical response to a concussion in a rat model combining force and rotation.

J Neurosurg. Genius J, Geiger J, Bender A, Möller HJ, Klopstock T, Rujescu D. Creatine protects against excitoxicity in an in vitro model of neurodegeneration. PLoS ONE. Saraiva ALL, Ferreira APO, Silva LFA, Hoffmann MS, Dutra FD, Furian AF, et al.

Creatine reduces oxidative stress markers but does not protect against seizure susceptibility after severe traumatic brain injury. Brain Res Bull. Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, et al.

Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. J Trauma. Sakellaris G, Nasis G, Kotsiou M, Tamiolaki M, Charissis G, Evangeliou A.

Prevention of traumatic headache, dizziness and fatigue with creatine administration: a pilot study. Acta Paediatr. Chaychi S, Valera E, Tartaglia MC. Int Rev Neurobiol. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress.

Nat Rev Drug Discov. Ravina BM, Fagan SC, Hart RG, Hovinga CA, Murphy DD, Dawson TM, et al. Creatine and multiple sclerosis. Nutr Neurosci. Soria Lopez JA, González HM, Léger GC. Handb Clin Neurol. Rijpma A, van der Graaf M, Meulenbroek O, Olde Rikkert MGM, Heerschap A. NeuroImage Clin.

Pettegrew JW, Panchalingam K, Klunk WE, McClure RJ, Muenz LR. Neurobiol Aging. Aksenov MY, Aksenova MV, Payne RM, Smith CD, Markesbery WR, Carney JM.

Exp Neurol. Laakso MP, Hiltunen Y, Könönen M, Kivipelto M, Koivisto A, Hallikainen M, et al. Decreased brain creatine levels in elderly apolipoprotein E ε4 carriers.

J Neural Transm. Brewer GJ, Wallimann TW. Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons. J Neurochem. Perez Ortiz JM, Swerdlow RH. Br J Pharmacol.

Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. Alimohammadi-Kamalabadi M, Eshraghian M, Zarindast M, Aliaghaei A, Pishva H. Iran J Basic Med Sci.

Ray Dorsey E, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Lancet Neurol. Sveinbjornsdottir S. Sagna A, Gallo JJ, Pontone GM.

Parkinsonism Relat Disord. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, et al. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Klein AM, Ferrante RJ. The neuroprotective role of creatine. Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, et al. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

Li Z, Wang P, Yu Z, Cong Y, Sun H, Zhang J, et al. Eur Neurol. Ravina B, Kieburtz K, Tilley B, Shannon K, Tanner C, Frederick Wooten G, et al. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Kieburtz K, Tilley B, Ravina B, Galpern WR, Shannon K, Tanner C, et al.

A pilot clinical trial of creatine and minocycline in early Parkinson disease: month results. Clin Neuropharmacol. Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, et al.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review.

Goldenberg MM. Multiple sclerosis review. Pharm Ther. Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Exercise as medicine in multiple sclerosis: time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep.

Taul-Madsen L, Connolly L, Dennett R, Freeman J, Dalgas U, Hvid LG. Is aerobic or resistance training the most effective exercise modality for improving lower extremity physical function and perceived fatigue in people with multiple sclerosis?

A systematic review and meta-analysis. Arch Phys Med Rehabil. Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, et al.

Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Lynch J, Peeling J, Auty A, Sutherland G. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis. Can J Neurol Sci. Lambert CP, Archer RL, Carrithers JA, Fink WJ, Evans WJ, Trappe TA.

Influence of creatine monohydrate ingestion on muscle metabolites and intense exercise capacity in individuals with multiple sclerosis. Malin SK, Cotugna N, Fang CS.

Effect of creatine supplementation on muscle capacity in individuals with multiple sclerosis. J Diet Suppl. Zucchi E, Bonetto V, Sorarù G, Martinelli I, Parchi P, Liguori R, et al.

Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener. Gittings LM, Sattler R. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.

Fac Rev. Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Tarnopolsky MA, Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

Beal MF. Neuroprotective effects of creatine. Klopstock T, Elstner M, Bender A. Creatine in mouse models of neurodegeneration and aging.

Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve. Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.

Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. Andreassen OA, Jenkins BG, Dedeoglu A, Ferrante KL, Bogdanov MB, Kaddurah-Daouk R, et al.

Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. Derave W, Van Den Bosch L, Lemmens G, Eijnde BO, Robberecht W, Hespel P. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.

Neurobiol Dis. Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R, et al. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci. Groeneveld GJ, Veldink JH, Van der Tweel I, Kalmijn S, Beijer C, De Visser M, et al.

A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Rosenfeld J, King RM, Jackson CE, Bedlack RS, Barohn RJ, Dick A, et al. Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. Amyotroph Lateral Scler.

Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, et al. A clinical trial of creatine in ALS. Drory VE, Gross D. No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. Tarnopolsky M, Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.

Balestrino M, Adriano E. Beyond sports: efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle. Med Res Rev.

Fitch CD, Moody LG. Creatine metabolism in skeletal muscle. An intracellular abnormality of creatine trapping in dystrophic muscle. Proc Soc Exp Biol Med. Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of patients.

Acta Myol. Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord.

Louis M, Lebacq J, Poortmans JR, Belpaire-Dethiou M-C, Devogelaer J-P, Van HP, et al. Beneficial effects of creatine supplementation in dystrophic patients. Ogborn DI, Smith KJ, Crane JD, Safdar A, Hettinga BP, Tupler R, et al.

Effects of creatine and exercise on skeletal muscle of FRG1-transgenic mice. Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, Roy BD, et al.

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

Davidson ZE, Hughes I, Ryan MM, Kornberg AJ, Cairns AG, Jones K, et al. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: a randomized controlled trial.

Clin Nutr. Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

Walter MC, Reilich P, Lochmüller H, Kohnen R, Schlotter B, Hautmann H, et al. Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study. J Neurol. Schneider-Gold C, Beck M, Wessig C, George A, Kele H, Reiners K, et al.

Proximal myotonic myopathy. Tarnopolsky M. Clinical use of creatine in neuromuscular and neurometabolic disorders. Kley R, Tarnopolsky M, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev. McCorquodale D, Pucillo EM, Johnson NE. Management of Charcot—Marie—Tooth disease: improving long-term care with a multidisciplinary approach.

J Multidiscip Healthc. Doherty TJ, Lougheed K, Markez J, Tarnopolsky MA. Creatine monohydrate does not increase strength in patients with hereditary neuropathy.

Chetlin RD, Gutmann L, Tarnopolsky MA, Ullrich IH, Yeater RA. Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Smith CA, Chetlin RD, Gutmann L, Yeater RA, Alway SE.

Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot—Marie—Tooth disease. World Health Organization. Wiles NJ, Thomas L, Turner N, Garfield K, Kounali D, Campbell J, et al.

Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.

Lancet Psychiatry. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Jung WY, Jang SH, Kim SG, Jae YM, Kong BG, Kim HC, et al. Times to discontinue antidepressants over 6 months in patients with major depressive disorder. Psychiatry Investig. Cartwright C, Gibson K, Read J, Cowan O, Dehar T.

Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA.

The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C]WAY positron emission tomography study.

Biol Psychiatry. Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Abdallah CG, Averill CL, Salas R, Averill LA, Baldwin PR, Krystal JH, et al.

Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment. Biol Psychiatry Cogn Neurosci Neuroimaging.

Persson J, Wall A, Weis J, Gingnell M, Antoni G, Lubberink M, et al. Inhibitory and excitatory neurotransmitter systems in depressed and healthy: a positron emission tomography and magnetic resonance spectroscopy study.

Psychiatry Res Neuroimaging. Kumar A, Thomas A, Lavretsky H, Yue K, Huda A, Curran J, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry. Li BSY, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy.

Magn Reson Imaging. Chang L, Mehringer CM, Ernst T, Melchor R, Myers H, Forney D, et al. Neurochemical alterations in asymptomatic abstinent cocaine users: a proton magnetic resonance spectroscopy study.

Faulkner P, Lucini Paioni S, Kozhuharova P, Orlov N, Lythgoe DJ, Daniju Y, et al. Daily and intermittent smoking are associated with low prefrontal volume and low concentrations of prefrontal glutamate, creatine, myo-inositol, and N -acetylaspartate. Addict Biol. Prescot AP, Locatelli AE, Renshaw PF, Yurgelun-Todd DA.

Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Allah Yar R, Akbar A, Iqbal F. Brain Res.

Öngür D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Biol Psychiatr. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol.

Faulkner P, Paioni SL, Kozhuharova P, Orlov N, Lythgoe DJ, Daniju Y, et al. Relationship between depression, prefrontal creatine and grey matter volume.

J Psychopharmacol. Yue Q, Liu M, Nie X, Wu Q, Li J, Zhang W, et al. Quantitative 3. Lyoo IK, Yoon S, Kim TS, Hwang J, Kim JE, Won W, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.

Nemets B, Levine J. Int Clin Psychopharmacol. Braissant O. Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. van de Kamp JM, Pouwels PJW, Aarsen FK, ten Hoopen LW, Knol DL, de Klerk JB, et al.

Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. Pazini FL, Cunha MP, Rosa JM, Colla ARS, Lieberknecht V, Oliveira Á, et al. Mol Neurobiol. Assis LC, Rezin GT, Comim CM, Valvassori SS, Jeremias IC, Zugno AI, et al.

The review highlighted robust evidence that clearly demonstrated the importance of creatine on cognitive function for individuals with creatine deficient syndromes, known to deplete brain creatine stores. Creatine deficiency syndrome is characterised by mental and developmental disorders such as learning delays and seizures, but these can be partly reversed by creatine supplementation, previous studies have shown.

Overall various cognitive tests have proven that creatine can augment measures of cognitive functions and that these cognitive effects appear to be more robust when brain bioenergetics are challenged, such as sleep deprivation.

The researchers felt that because of the positive effects of creatine on muscle strength, mass and functionality, looking at its potential to mitigate disease-related physical impairments common in neurogenerative diseases was justified.

The two most prevalent mental health conditions are depression and generalised anxiety disorder and deficiency in creatine can affect intellectual disability, language delay seizure disorders, autism spectrum disorders and various motor movement disorders with the primary treatment being creatine monohydrate supplements in an attempt to increase the content of creatine in the brain.

After analysing several studies, the researchers concluded that while there is a possible role for creatine in the treatment of various forms of depression but much larger-scale, randomised studies are needed and should include measures of brain creatine. They that more work is also warranted in the possible use of creatine in the treatment of general anxiety disorder and post-traumatic stress disorder.

The reviewers noted that beyond muscle, accumulating research shows that creatine supplementation and GAA can increase brain creatine content which may explain some of the initial benefits for those with depression, concussion and other cognitive issues but there is a lack of research with inconsistencies regarding the efficacy of creatine particularly when it comes to treating symptoms of neurodegenerative diseases, anxiety, or PTSD.

Future research is needed to determine the mechanism and clinical effects on brain function and health. Published online: doi. Show more. Content provided by Natural Remedies Private Limited Jan White Paper. While this method takes longer 3 hours compared to 15 minutes , patients typically see results on a faster timeline as IV therapy allows for better absorption rates.

Neurofeedback therapy , once only available to athletes and executives, is now readily available to the public to improve cognitive function. Neurofeedback therapy typically takes months to start producing results. This holistic assessment includes a cognitive test, a bone density scan, and a blood draw that measures 55 biomarkers that impact the aging process.

Unsure where to start? Book a free consultation today. My Account.

Creatine monohydrate is one of the Creatine for enhancing brain performance popular Lentil-based comfort food recipes effective sport supplements around, but Creatime of the marketing is aimed at its very legitimate Creahine on perdormance muscle growth Creatine for enhancing brain performance performahce gain. Here are four surprising brain-related benefits of creatine, backed by science for your consideration. We are not a medical resource. Before you dive into all the fun neuroscience of creatine, you should have a working understanding of it as both a supplement and a chemical compound. Creatine plays important roles in rapid energy production and protection against oxidative stress. Enhancinng is a Creatine for enhancing brain performance supplement often used braib improve athletic performance. Creatinne may also boost brain function, fight certain neurological flr, and accelerate muscle growth. Creatine for enhancing brain performance is a natural supplement used to performacne athletic performance 1. Phosphocreatine Hydration status analysis the formation of adenosine triphosphate ATPthe key molecule your cells use for energy and all basic life functions 8. The rate of ATP resynthesis limits your ability to continually perform at maximum intensity, as you use ATP faster than you reproduce it 9 Creatine supplements increase your phosphocreatine stores, allowing you to produce more ATP energy to fuel your muscles during high-intensity exercise 10 Creatine is a popular and effective supplement for adding muscle mass 14.

Video

Nutrients For Brain Health \u0026 Performance - Huberman Lab Podcast #42

Author: Kigat

5 thoughts on “Creatine for enhancing brain performance

  1. Nach meiner Meinung sind Sie nicht recht. Geben Sie wir werden besprechen. Schreiben Sie mir in PM, wir werden reden.

  2. Ich entschuldige mich, aber meiner Meinung nach irren Sie sich. Ich kann die Position verteidigen. Schreiben Sie mir in PM, wir werden besprechen.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com